Back to Press Releases

KKR Invests in Healthcare Revenue Solutions Provider Infinx

May 21, 2024

MUMBAI, India–(BUSINESS WIRE)– KKR, a leading global investment firm, and Infinx Services Private Limited (“Infinx” or the ‘Company’), an AI-driven healthcare revenue cycle solutions provider, today announced the acquisition of a significant minority stake in Infinx by a KKR-managed fund. Through this investment, KKR will leverage its extensive experience in the global healthcare and technology sectors to accelerate Infinx’s growth, expand the Company’s network, and support bolt-on acquisitions. Norwest Venture Partners, an existing shareholder, also participated in the transaction.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240520027338/en/

Co-founded in 2012 by Sandeep Tandon and Jaideep Tandon, Infinx is a provider of innovative, data-driven revenue cycle management solutions for the healthcare sector, with a particular focus on the US market. Infinx’s Healthcare Revenue Cloud platform supports end-to-end revenue cycle business functions utilizing AI, automation, payer integration, and workforce management. Recent reports have valued the US healthcare market at approximately $4.3 trillion, representing over 18% of US GDP1. Today, Infinx’s solutions support 172,000 healthcare professionals across 4,000 facilities including ambulatory, acute care and post-acute care providers. Infinx counts over 400 leading healthcare provider organizations as customers including hospitals, health systems and outpatient healthcare providers. In 2023, Infinx was ranked as a top RCM vendor by healthcare research firms Everest Group2 and Black Book Research3.

Akshay Tanna, Partner and Head of India Private Equity, KKR, said, “Digital transformation will play an increasingly important role in helping companies to streamline complex processes and improve productivity. Considering this tailwind, we are pleased to invest in Infinx given its comprehensive suite of flexible, tech-enabled offerings, strong management team and proven ability to serve healthcare providers. We look forward to leveraging KKR’s industry and operational expertise to further enhance Infinx’s scale and capabilities, and collaborating closely with Jaideep, Sudeep and their talented team to take Infinx to its next stage of growth.”

Jaideep Tandon, CEO of Infinx, added, “We are thrilled to collaborate with KKR, one of the most experienced investors in the global healthcare and technology sectors with a track record of supporting some of the world’s most notable and innovative companies. Infinx has been a leader in the healthcare revenue cycle and an early adopter of automation and AI technologies. With KKR’s support, network and differentiated expertise, we are even better positioned to accelerate our growth, continue our investment in innovative solutions to help improve the financial health of healthcare providers. Our customers have come to rely on our solutions to reduce administrative burden and revenue leakage so that they can focus on what they do best – delivering exceptional care to their patients and broadening the access to healthcare.”

Sudeep Tandon, Managing Director of Infinx, commented, “The strategic partnership with KKR will allow us to accelerate our growth through continued strategic acquisitions and to broaden our market reach to new healthcare specialties. We look forward to leveraging KKR’s deep healthcare and technology experience to increase our investments in AI, predictive analytics and automation.”

Shiv Chaudhary, Managing Director of Norwest India, added, “Infinx has delivered high growth and built a strong foundation since our first investment in 2021. We are excited to invest further in this financing and welcome KKR as an investor. With its differentiated offering, seasoned team and proven customer success, Infinx is well positioned to become a leader in this very large market.”

KKR makes its investment from its Asian Fund IV. The transaction marks KKR’s latest investment in technology services and healthcare, which includes, but is not limited to, past and current investments including Cloudera, a provider of enterprise-grade, hybrid data management software in the US; Ness Digital Engineering, a global full-lifecycle digital services transformation company; Yayoi, a software developer, distributor, and support service provider for small-and-medium-sized enterprises in Japan; Probe CX, a provider of outsourced customer experience and business process outsourcing solutions in Australia; MYOB, an Australian online business management company; Jio, a next-generation technology platform that provides digital services across India; Healthium Medtech, a leading Indian medical devices company; Max Healthcare, a private hospital network in India; and JB, a pharmaceutical company specializing in branded formulations in India.

Additional details of the transaction are not disclosed.

Infinx was advised by Rothschild & Co. as financial advisor.

About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

About Infinx

Infinx provides innovative and scalable AI-driven solutions designed to optimize the financial lifecycle of healthcare providers across all functions within patient access and revenue cycle management. Combining intelligent, cloud-based software driven by artificial intelligence and automation, with support from consultants and billing specialists, Infinx helps clients preserve and capture more revenue, enabling them to shift focus from burdensome administrative tasks to patient care. By partnering with Infinx, providers stay a few steps ahead of ever-changing government regulations and payer guidelines so that they focus on strategically growing their business. Founded in 2012, Infinx has a global team across the US, India and Philippines. For more information, visit www.infinx.com.

1 Health Affairs (2022): National Health Care Spending In 2021: Decline In Federal Spending Outweighs Greater Use of Health Care
2 Everest Group (2023): Revenue Cycle Management (RCM) Trailblazers
3 Black Book Research (2023): Finance – Revenue Cycle Management

For KKR Asia Pacific
Wei Jun Ong
+65 6922 5813
WeiJun.Ong@kkr.com

AdFactors (for KKR India)
Jinal Parekh
+91 9869657529
Jinal.Parekh@adfactorspr.com

For Infinx Healthcare
Erin Wabol
+1 727 599 7876
erin.wabol@infinx.com

Source: KKR


Download PDF

Back to Press Releases

Media Contacts

Americas

Kristi Huller
Julia Kosygina
Liidia Liuksila
Telephone: +1 (212) 750-8300

Email: media@kkr.com

EMEA

Annabel Arthur
Miles Radcliffe-Trenner
Julia Leeger
Telephone: +44 20 7839 9800

Email: kkrpr-uk@kkr.com

Asia-Pacific

Wei Jun Ong
Telephone: +852 3602 7335

Email: media@kkr.com

Investor Relations

‍Craig Larson
Telephone: +1 (877) 610-4910
Outside US: +1 (212) 230-9410
Facsimile: +1 (212) 750-0003
Email: Investor-Relations@kkr.com

×

Listen to webcast

This presentation contains certain forward-looking statements pertaining to KKR & Co. Inc. and its consolidated subsidiaries (collectively “KKR”), including certain investment funds, vehicles and accounts that are managed by KKR (each, a “fund”). Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. The forward-looking statements are based on KKR’s beliefs, assumptions and expectations of its future performance, taking into account all information currently available to it. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to KKR or are within its control. If a change occurs, KKR’s business, financial condition, liquidity and results of operations, including but not limited to, assets under management, fee paying assets under management, after-tax distributable earnings, capital invested, syndicated capital, uncalled commitments, cash and short-term investments, fee related earnings, fee and yield segment EBITDA, core interest expense and book value, may vary materially from those expressed in the forward-looking statements. The following factors, among others, could cause actual results to vary from the forward-looking statements: whether KKR realizes all or any of the anticipated benefits from converting to a corporation and the timing of realizing such benefits; whether there are increased or unforeseen costs associated with the conversion, including any adverse change in tax law; the volatility of the capital markets; the general volatility of the capital markets; failure to realize the benefits of or changes in KKR’s business strategies including the ability to realize the anticipated synergies from acquisitions or strategic partnerships or other transactions; availability, terms and deployment of capital; availability of qualified personnel and expense of recruiting and retaining such personnel; changes in the asset management industry, interest rates or the general economy; underperformance of KKR's investments and decreased ability to raise funds; and the degree and nature of KKR’s competition. All forward-looking statements speak only as of the date they are made. KKR does not undertake any obligation to update any forward-looking statements to reflect circumstances or events that occur after the date on which such statements were made except as required by law. In addition, KKR’s business strategy is focused on the long-term and financial results are subject to significant volatility.

Additional information about factors affecting KKR, including a description of risks that may be important to a decision to purchase or sell any common or preferred stock of KKR & Co. Inc., can be found in KKR & Co. Inc.’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and its other filings with the SEC, which are available at www.sec.gov.

I understand  |   Go back
×

Listen to Presentation

Before viewing this presentation, please acknowledge your understanding that it has been prepared for KKR & Co. Inc. (NYSE:KKR) for the benefit of its public stockholders and is not intended to be a solicitation or sale of any of the securities, funds or services that it may discuss. Please click on "I understand" to view the presentation.

I understand  |   Go back